Abordaje integral del cáncer gástrico avanzado - page 37

TRATAMIENTO

SEGUNDA LÍNEA

RETRATAMIENTO

IRINOTECAN

DOCETAXEL

PACLITAXEL

PS 0 – 1.

SVG 5 a 9 m.

Toxicidad.

QoL.

QUIMIOTERAPIA SEGUNDA LÍNEA

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,27,28,29,30,31,32,33,34,35,36 38,39,40,41,42,43,44,45,46,47,...65